About Aarhus Universitetshospital, Hæmatologisk Afdeling R
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Aarhus Universitetshospital, Hæmatologisk Afdeling R
During the past decade, Aarhus Universitetshospital, Hæmatologisk Afdeling R conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
2003-07-31
2012-05-31
Completed
552
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aarhus Universitetshospital, Hæmatologisk Afdeling R"
#1 collaborator was "Biogen" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Aarhus Universitetshospital, Hæmatologisk Afdeling R
According to Clinical.Site data, the most researched conditions in "Aarhus Universitetshospital, Hæmatologisk Afdeling R" are
"Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Aarhus Universitetshospital, Hæmatologisk Afdeling R" in a lesser frequency.
Clinical Trials Intervention Types at Aarhus Universitetshospital, Hæmatologisk Afdeling R
Most popular intervention types in "Aarhus Universitetshospital, Hæmatologisk Afdeling R" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Doxorubicin" (2 trials), "Rituximab" (2 trials), "Vincristine" (2 trials) and "Fludarabine Phosphate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aarhus Universitetshospital, Hæmatologisk Afdeling R
The vast majority of trials in "Aarhus Universitetshospital, Hæmatologisk Afdeling R" are
3 trials for "All" genders.
Clinical Trials Status at Aarhus Universitetshospital, Hæmatologisk Afdeling R
Currently, there are NaN active trials in "Aarhus Universitetshospital, Hæmatologisk Afdeling R".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Aarhus Universitetshospital, Hæmatologisk Afdeling R,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Aarhus Universitetshospital, Hæmatologisk Afdeling R, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".